299 related articles for article (PubMed ID: 9126150)
1. Dopaminergic transplants in patients with Parkinson's disease: neuroanatomical correlates of clinical recovery.
Kordower JH; Goetz CG; Freeman TB; Olanow CW
Exp Neurol; 1997 Mar; 144(1):41-6. PubMed ID: 9126150
[TBL] [Abstract][Full Text] [Related]
2. Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease.
Kordower JH; Freeman TB; Chen EY; Mufson EJ; Sanberg PR; Hauser RA; Snow B; Olanow CW
Mov Disord; 1998 May; 13(3):383-93. PubMed ID: 9613726
[TBL] [Abstract][Full Text] [Related]
3. Putative chromaffin cell survival and enhanced host-derived TH-fiber innervation following a functional adrenal medulla autograft for Parkinson's disease.
Kordower JH; Cochran E; Penn RD; Goetz CG
Ann Neurol; 1991 Apr; 29(4):405-12. PubMed ID: 1681779
[TBL] [Abstract][Full Text] [Related]
4. Intranigral transplants of GABA-rich striatal tissue induce behavioral recovery in the rat Parkinson model and promote the effects obtained by intrastriatal dopaminergic transplants.
Winkler C; Bentlage C; Nikkhah G; Samii M; Björklund A
Exp Neurol; 1999 Feb; 155(2):165-86. PubMed ID: 10072293
[TBL] [Abstract][Full Text] [Related]
5. Cells of the sympathoadrenal lineage: biological properties as donor tissue for cell-replacement therapies for Parkinson's disease.
Fernandez-Espejo E; Armengol JA; Flores JA; Galan-Rodriguez B; Ramiro S
Brain Res Brain Res Rev; 2005 Sep; 49(2):343-54. PubMed ID: 16111561
[TBL] [Abstract][Full Text] [Related]
6. A sequential intrastriatal dopaminergic graft strategy in the rodent model for Parkinson's disease: implications for graft survival and targeting.
Baker KA; Purdy MB; Sadi D; Mukhida K; Mendez I
Cell Transplant; 2002; 11(3):185-93. PubMed ID: 12075984
[TBL] [Abstract][Full Text] [Related]
7. Continuous exposure to glial cell line-derived neurotrophic factor to mature dopaminergic transplants impairs the graft's ability to improve spontaneous motor behavior in parkinsonian rats.
Winkler C; Georgievska B; Carlsson T; Lacar B; Kirik D
Neuroscience; 2006 Aug; 141(1):521-31. PubMed ID: 16697115
[TBL] [Abstract][Full Text] [Related]
8. [Cografts of adrenal medulla and peripheral nerve in a mouse model of Parkinson's disease].
Date I; Asari S; Nishimoto A; Felten D
No Shinkei Geka; 1991 Sep; 19(9):811-5. PubMed ID: 1944788
[TBL] [Abstract][Full Text] [Related]
9. [Neural transplants en Parkinson disease: clinical results of 10 years of experience. Group of Neural Transplants of the CPH].
López-Lozano JJ; Mata M; Bravo G
Rev Neurol; 2000 Jun 1-15; 30(11):1077-83. PubMed ID: 10904957
[TBL] [Abstract][Full Text] [Related]
10. Adjunctive use of the non-ionic surfactant Poloxamer 188 improves fetal dopaminergic cell survival and reinnervation in a neural transplantation strategy for Parkinson's disease.
Quinn M; Mukhida K; Sadi D; Hong M; Mendez I
Eur J Neurosci; 2008 Jan; 27(1):43-52. PubMed ID: 18093176
[TBL] [Abstract][Full Text] [Related]
11. [Cografting technique in the treatment of Parkinson's disease].
Date I; Asari S; Nishimoto A; Felten D
No Shinkei Geka; 1991 Oct; 19(10):919-24. PubMed ID: 1944775
[TBL] [Abstract][Full Text] [Related]
12. Neuropathology of fetal nigral grafts in patients with Parkinson's disease.
Kordower JH; Freeman TB; Olanow CW
Mov Disord; 1998; 13 Suppl 1():88-95. PubMed ID: 9613724
[No Abstract] [Full Text] [Related]
13. Does adrenal graft enhance recovery of dopaminergic neurons in Parkinson's disease?
Hirsch EC; Duyckaerts C; Javoy-Agid F; Hauw JJ; Agid Y
Ann Neurol; 1990 Jun; 27(6):676-82. PubMed ID: 2360804
[TBL] [Abstract][Full Text] [Related]
14. Embryonic ventral mesencephalic grafts to the substantia nigra of MPTP-treated monkeys: feasibility relevant to multiple-target grafting as a therapy for Parkinson's disease.
Collier TJ; Sortwell CE; Elsworth JD; Taylor JR; Roth RH; Sladek JR; Redmond DE
J Comp Neurol; 2002 Jan; 442(4):320-30. PubMed ID: 11793337
[TBL] [Abstract][Full Text] [Related]
15. [Experimental clinical transplantation in patients with Parkinson disease. Experimental background and clinical picture].
Ostergaard K; Rasmussen JZ
Ugeskr Laeger; 1991 Dec; 153(50):3554-8. PubMed ID: 1776197
[TBL] [Abstract][Full Text] [Related]
16. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
During MJ; Kaplitt MG; Stern MB; Eidelberg D
Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous intrastriatal and intranigral dopaminergic grafts in the parkinsonian rat model: role of the intranigral graft.
Baker KA; Sadi D; Hong M; Mendez I
J Comp Neurol; 2000 Oct; 426(1):106-16. PubMed ID: 10980486
[TBL] [Abstract][Full Text] [Related]
18. Pattern of long-term sensorimotor recovery following intrastriatal and--accumbens DA micrografts in a rat model of Parkinson's disease.
Falkenstein G; Rosenthal C; Reum T; Morgenstern R; Döbrössy M; Nikkhah G
J Comp Neurol; 2009 Jul; 515(1):41-55. PubMed ID: 19399892
[TBL] [Abstract][Full Text] [Related]
19. [Intraparenchymal and intraventricular transplantation of fetal substantia nigra cell suspension in rat model of Parkinson's disease].
Yang H; Zhang K; Cai W
Zhonghua Wai Ke Za Zhi; 1997 Jan; 35(1):19-21. PubMed ID: 10374501
[TBL] [Abstract][Full Text] [Related]
20. Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient.
Piccini P; Brooks DJ; Björklund A; Gunn RN; Grasby PM; Rimoldi O; Brundin P; Hagell P; Rehncrona S; Widner H; Lindvall O
Nat Neurosci; 1999 Dec; 2(12):1137-40. PubMed ID: 10570493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
